Unresectable Gallbladder Carcinoma: Clinical Trials

1 trial for Unresectable Gallbladder Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Completed 1

Follow Unresectable Gallbladder Carcinoma: new trials by email Literature Review of Unresectable Gallbladder Carcinoma trials Research Report on Unresectable Gallbladder Carcinoma

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers
Cisplatin, Gemcitabine Hydrochloride, Nab-paclitaxel - Stage III Distal Bile Duct Cancer AJCC v8, Stage III Gallbladder Cancer AJCC v8
Phase 3CompletedSWOG Cancer Research Network4522019-02-072026-01-12

Narrower conditions

Cholangiocarcinoma (1)  ·  Gallbladder Neoplasms (1)

Broader conditions

Adenocarcinoma (1)  ·  Biliary Tract Diseases (1)  ·  Biliary Tract Neoplasms (1)  ·  Carcinoma (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gallbladder Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Glandular and Epithelial (1)

Interventions

1,2-diaminocyclohexaneplatinum II citrate (1)  ·  130-nm albumin-bound paclitaxel (1)  ·  Albumin-Bound Paclitaxel (1)  ·  Cisplatin (1)  ·  Gemcitabine (1)  ·  Platinum (1)  ·  Taxes (1)

Sponsors

SWOG Cancer Research Network (1)

Countries

United States (1)

Top investigators

Rachna Shroff (1)

Results publications

PMID 39671534

NIH funding

U10CA180888 (1)